Abstract #2370
Evaluation of the feasibility to use novel tissue engineered grafts for right ventricular outflow tract reconstruction by magnetic resonance imaging
Dagmar Hartung 1 , Serghei Cebotari 2 , Igor Tudorache 2 , Karolina Theodoridis 2 , Tanja Meyer 2 , Alexandru Mogaldea 2 , Robert Ramm 3 , Katja Hueper 1 , Frank Wacker 1 , Andres Hilfiker 3 , and Axel Haverich 2
1
Radiology, Hannover Medical School,
Hannover, Germany,
2
Division
of Cardiothoracic, Transplantation, and Vascular
Surgery, Hannover Medical School, Hannover, Germany,
3
Leibniz
Research Laboratory for Biotechnology and Artificial
Organs, Hannover Medical School, Hannover, Germany
In various congenital heart diseases reconstruction of
the right ventricular outflow tract (RVOT) is necessary.
Pericardium is the currently used material. To improve
longterm graft survival new approaches based on
regenerative medicine are being developed. We evaluated
the feasibility of a novel tissue engineered (TE) graft
composed of an allogeneic TE valve combined with an
autologous vascularized patch of small intestine
(AutoVaM) for RVOT-reconstruction in pigs by MRI. A
graft consisting of a TE valve combined with a
pericardial patch served as control. Morphological and
functional properties of the new AutoVaM-graft were
superior to the conventional pericardial graft for
RVOT-reconstruction.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.